Kashiv BioSciences, a leading biopharmaceutical company, has secured Rs 648 crore in financing from the Union Bank of India to expand its manufacturing capabilities.

The funding will be used to develop a new, state-of-the-art single-use commercial manufacturing facility located in Pipan, near Ahmedabad, Gujarat. This facility, one of the largest of its kind in India, will be equipped with advanced technologies to support the production of high-quality biologics and specialty pharmaceuticals. Once fully operational, it will have the capacity to manufacture up to 50,000L of products. This expansion is a significant step in Kashiv's global growth strategy and aims to position India as a hub for advanced biopharmaceutical manufacturing.

Serving markets across the US., Canada, Europe, and other regions, the facility will enhance India's role in the global pharmaceutical industry, while creating valuable employment opportunities in scientific and technical fields.